Dynamic and static circulating cancer microRNA biomarkers – a validation study

References

• Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157(1):77–94.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854.
   PubMed Web of Science ®Google Scholar
• Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855–862.
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155–D62.
   PubMed Web of Science ®Google Scholar
• Fromm B, Domanska D, Hoye E, et al. MirGeneDB 2.0: the metazoan microRNA complement. Nucleic Acids Res. 2020;48(D1):D132–D41.
   PubMed Web of Science ®Google Scholar
• Fromm B, Hoye E, Domanska D, et al. MirGeneDB 2.1: toward a complete sampling of all major animal phyla. Nucleic Acids Res. 2022;50(D1):D204–D10.
   PubMed Web of Science ®Google Scholar
• Backes C, Fehlmann T, Kern F, et al. miRCarta: a central repository for collecting miRNA candidates. Nucleic Acids Res. 2018;46(D1):D160–D7.
   PubMed Web of Science ®Google Scholar
• Keller A, Groger L, Tschernig T, et al. miRNATissueAtlas2: an update to the human miRNA tissue atlas. Nucleic Acids Res. 2022;50(D1):D211–D21.
   PubMed Web of Science ®Google Scholar
• Ludwig N, Leidinger P, Becker K, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865–3877.
   PubMed Web of Science ®Google Scholar
• Smith CM, Hutvagner G. A comparative analysis of single cell small RNA sequencing data reveals heterogeneous isomiR expression and regulation. Sci Rep. 2022;12(1):2834.
   PubMed Web of Science ®Google Scholar
• Telonis AG, Magee R, Loher P, et al. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res. 2017;45:2973–2985.
   PubMed Web of Science ®Google Scholar
• Telonis AG, Loher P, Jing Y, et al. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res. 2015;43:9158–9175.
   PubMed Web of Science ®Google Scholar
• Vaz C, Ahmad HM, Bharti R, et al. Analysis of the microRNA transcriptome and expression of different isomiRs in human peripheral blood mononuclear cells. BMC Res Notes. 2013;6(1):390.
   PubMedGoogle Scholar
• Merchant ML, Rood IM, Deegens JKJ, et al. Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol. 2017;13(12):731–749.
   PubMed Web of Science ®Google Scholar
• Lempriere S. Exosomal microRNA is promising biomarker in PD. Nat Rev Neurol. 2022;18:65.
   Google Scholar
• Chen Y, Buyel JJ, Hanssen MJ, et al. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun. 2016;7(1):11420.
   PubMedGoogle Scholar
• Knarr M, Avelar RA, Sekhar SC, et al. miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling. Nat Commun. 2020;11(1):3231.
   PubMed Web of Science ®Google Scholar
• Yokoi A, Matsuzaki J, Yamamoto Y, et al. Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun. 2018;9(1):4319.
   PubMedGoogle Scholar
• Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9(1):5395.
   PubMed Web of Science ®Google Scholar
• Kern F, Fehlmann T, Violich I, et al. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression. Nature Aging. 2021;1(3):309–322.
   PubMedGoogle Scholar
• Fehlmann T, Lehallier B, Schaum N, et al. Common diseases alter the physiological age-related blood microRNA profile. Nat Commun. 2020;11(1):5958.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Kahraman M, Ludwig N, et al. Evaluating the use of circulating MicroRNA profiles for lung cancer detection in symptomatic patients. JAMA Oncol. 2020;6(5):714–723.
   PubMed Web of Science ®Google Scholar
• Keller A, Fehlmann T, Backes C, et al. Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis. RNA Biol. 2020;17(10):1416–1426.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Gislefoss R, et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 2011;8(3):506–516.
   PubMed Web of Science ®Google Scholar
• Keller A, Rounge T, Backes C, et al. Sources to variability in circulating human miRNA signatures. RNA Biol. 2017;14(12):1791–1798.
   PubMed Web of Science ®Google Scholar
• Umu SU, Langseth H, Bucher-Johannessen C, et al. A comprehensive profile of circulating RNAs in human serum. RNA Biol. 2018;15(2):242–250.
   PubMed Web of Science ®Google Scholar
• Rounge TB, Umu SU, Keller A, et al. Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity. Sci Rep. 2018;8(1):17650.
   PubMedGoogle Scholar
• Langseth H, Gislefoss RE, Martinsen JI, et al. Cohort Profile: the janus serum bank cohort in Norway. Int J Epidemiol. 2017;46(2):403–4g.
   PubMed Web of Science ®Google Scholar
• Rounge TB, Lauritzen M, Langseth H, et al. Gislefoss RE. microRNA biomarker discovery and high-throughput DNA sequencing are possible using long-term archived serum samples. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1381–1387.
   PubMed Web of Science ®Google Scholar
• Backes C, Sedaghat-Hamedani F, Frese K, et al. Bias in high-throughput analysis of miRNAs and Implications for biomarker studies. Anal Chem. 2016;88(4):2088–2095.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Lehallier B, Schaum N, et al. Common diseases alter the physiological age-related blood microRNA profile. Nat Commun. 2020;11(1):5958.
   PubMed Web of Science ®Google Scholar
• Cui C, Yang W, Shi J, et al. Identification and analysis of human sex-biased MicroRNAs. Genomics Proteomics Bioinformatics. 2018;16(3):200–211.
   PubMed Web of Science ®Google Scholar
• Huang RS, Gamazon ER, Ziliak D, et al. Population differences in microRNA expression and biological implications. RNA Biol. 2011;8(4):692–701.
   PubMed Web of Science ®Google Scholar
• Cervena K, Novosadova V, Pardini B, et al. Analysis of MicroRNA Expression changes during the course of therapy in rectal cancer patients. Front Oncol. 2021;11:702258.
   PubMed Web of Science ®Google Scholar
• Hecksteden A, Leidinger P, Backes C, et al. miRNAs and sports: tracking training status and potentially confounding diagnoses. J Transl Med. 2016;14(1):219.
   PubMedGoogle Scholar
• Ludwig N, Hecksteden A, Kahraman M, et al. Spring is in the air: seasonal profiles indicate vernal change of miRNA activity. RNA Biol. 2019;16(8):1034–1043.
   PubMed Web of Science ®Google Scholar
• Li J, Han X, Wan Y, et al. TAM 2.0: tool for MicroRNA set analysis. Nucleic Acids Res. 2018;46(W1):W180–W5.
   PubMed Web of Science ®Google Scholar
• Shi J, Cui Q. sTAM: an online tool for the discovery of miRNA-Set level disease biomarkers. Mol Ther Nucleic Acids. 2020;21:670–675.
   PubMedGoogle Scholar
• Kern F, Fehlmann T, Solomon J, et al. miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems. Nucleic Acids Res. 2020;48(W1):W521–W8.
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhong M, Zeng S, et al. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance. Epigenomics. 2019;11(1):35–51.
   PubMed Web of Science ®Google Scholar
• Garrido-Cano I, Pla L, Santiago-Felipe S, et al. Nanoporous anodic alumina-based sensor for miR-99a-5p detection as an effective early breast cancer diagnostic tool. ACS Sens. 2021;6(3):1022–1029.
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Sawada K, Nakamura K, et al. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. BMC Cancer. 2018;18(1):1065.
   PubMedGoogle Scholar
• Yu X, Liang J, Xu J, et al. Identification and validation of circulating MicroRNA signatures for breast cancer early detection based on large scale tissue-derived data. J Breast Cancer. 2018;21(4):363–370.
   PubMed Web of Science ®Google Scholar
• Kern F, Krammes L, Danz K, et al. Validation of human microRNA target pathways enables evaluation of target prediction tools. Nucleic Acids Res. 2021;49(1):127–144.
   PubMed Web of Science ®Google Scholar
• Chan YT, Lin YC, Lin RJ, et al. Concordant and discordant regulation of target genes by miR-31 and its isoforms. PLoS One. 2013;8(3):e58169.
   PubMed Web of Science ®Google Scholar
• Yu F, Pillman KA, Neilsen CT, et al. Naturally existing isoforms of miR-222 have distinct functions. Nucleic Acids Res. 2017;45(19):11371–11385.
   PubMed Web of Science ®Google Scholar
• Llorens F, Banez-Coronel M, Pantano L, et al. A highly expressed miR-101 isomiR is a functional silencing small RNA. BMC Genomics. 2013;14(1):104.
   PubMedGoogle Scholar
• Magee R, Telonis AG, Cherlin T, et al. Assessment of isomiR discrimination using commercial qPCR Methods. Noncoding RNA. 2017;3(1):3.
   PubMedGoogle Scholar
• Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther. 2016;20(6):509–518.
   PubMed Web of Science ®Google Scholar
• Umu SU, Langseth H, Keller A, et al. A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis. Mol Oncol. 2020;14(2):235–247.
   PubMed Web of Science ®Google Scholar
• Burton J, Umu SU, Langseth H, et al. Serum RNA profiling in the 10-years period prior to diagnosis of testicular germ cell tumor. Front Oncol. 2020;10:574977.
   PubMed Web of Science ®Google Scholar
• Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38(6):613–626.
   PubMed Web of Science ®Google Scholar